UK markets close in 1 hour 2 minutes

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8047+0.0441 (+5.80%)
As of 10:25AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 46.57M
Enterprise value 24.10M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.72
Price/book (mrq)0.48
Enterprise value/revenue 0.67
Enterprise value/EBITDA -0.11

Trading information

Stock price history

Beta (5Y monthly) 2.37
52-week change 3-89.73%
S&P500 52-week change 323.06%
52-week high 38.2000
52-week low 30.7100
50-day moving average 31.0832
200-day moving average 32.2863

Share statistics

Avg vol (3-month) 31.57M
Avg vol (10-day) 31.62M
Shares outstanding 561.23M
Implied shares outstanding 661.23M
Float 854.49M
% held by insiders 10.50%
% held by institutions 111.97%
Shares short (28 Mar 2024) 45.27M
Short ratio (28 Mar 2024) 43.69
Short % of float (28 Mar 2024) 49.67%
Short % of shares outstanding (28 Mar 2024) 49.64%
Shares short (prior month 29 Feb 2024) 45.23M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 307 Aug 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 0.00%
Operating margin (ttm)-269.97%

Management effectiveness

Return on assets (ttm)-33.39%
Return on equity (ttm)-134.56%

Income statement

Revenue (ttm)36.12M
Revenue per share (ttm)1.06
Quarterly revenue growth (yoy)30.50%
Gross profit (ttm)N/A
EBITDA -125.72M
Net income avi to common (ttm)-232.49M
Diluted EPS (ttm)-6.8100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)66.77M
Total cash per share (mrq)1.22
Total debt (mrq)79.41M
Total debt/equity (mrq)82.59%
Current ratio (mrq)1.40
Book value per share (mrq)2.10

Cash flow statement

Operating cash flow (ttm)-125.18M
Levered free cash flow (ttm)-97.73M